Global Antibody Drug Conjugate Market Examined by RNCOS E-Services in Research Report Available at MarketPublishers.com
08 Dec 2014 • by Natalie Aster
LONDON – The global market for antibody drug conjugates (ADC) is forecast to achieve the value of about USD 3 billion through 2018. The market is expected to demonstrate a high growth rate in the years ahead due to the approval of various ADCs, including ADCETRIS and Kadcyla drugs. Furthermore, the novel therapeutics development is predicted to be observed in the world ADC industry.
The on-going improvements in linker technology together with patent fencing through ADC development present the main factors fuelling the world ADC industry growth. Moreover, more companies are focusing on the ADC development in order to protect their innovative drugs. These aspects are anticipated to shape the overall ADC market in the following years. Meanwhile, ADCs manufacturing is rather costly and implies difficulties with their downstream and upstream processing. These factors, along with certain safety issues, are among the main problems faced by the ADCs producers.
The high number of new pharmaceutical companies entering the ADC industry will lead to the rising competition, which in turn will boost demand for ADC in the future. The ADC industry is expected to see the new partnerships and collaborations concluded by the major pharma firms, aimed at developing these drugs.
Topical market research report “Global Antibody Drug Conjugate Market Outlook 2018” developed by RNCOS E-Services Pvt. Ltd. offers key insights into the world antibody drug conjugates market. The comprehensive study comprises an all-round analysis of the global antibody drug conjugates industry and includes a detailed description of ADCETRIS and Kadcyla drugs. Besides, the report mentions key ADCs that are under trial now and examines ADCs based on the type of cancer targeted. The latest mergers, partnerships and acquisitions in the ADC marketplace are overviewed, too. In addition, the study analyzes key drivers and limiters of the world market development, discusses main companies engaged in the ADCs production, including extensive information on the latest developments and pipeline portfolio. Future market opportunities are discussed in the study as well.
Global Antibody Drug Conjugate Market Outlook 2018
Published: November, 2014
Price: US$ 1,200.00
More insightful market research studies by the publisher can be found at RNCOS E-Services page.